OAB-055: Updated results of a phase 1, first-in-human study of ABBV-383, a BCMA × CD3 bispecific T-cell redirecting antibody, in patients with relapsed/refractory multiple myeloma

Authors :: Peter Voorhees
Nina Shah
Anita D’Souza
Cesar Rodriguez
Katja Weisel
Raphael Teipel
David Hurd
Orlando Bueno
Neil Pumford
Tanya Rosenberg
Rajvineeth Kumar Pothacamury
Jeremy Ross
Akshanth Polepally
Shane Lee
Ziyi Jin
Chetasi Talati
Shaji Kumar
Ravi Vij
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S34
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools